There is a fast growing business of prescribed medicinal cannabis in Australia. it's currently around 3600 patients per month and the average spend is about $300.
that means there is $1m spent on cannabis per month.
This could be a great revenue opportunity for Auscann to sell their new hard shell cannabis pills on this via the Special Access Scheme.
What is stopping them from participating?
